Page last updated: 2024-09-04

dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination and Brain Disorders

dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination has been researched along with Brain Disorders in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Robertson, B; Speer, CP1

Trials

2 trial(s) available for dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination and Brain Disorders

ArticleYear
OSIRIS trial.
    Lancet (London, England), 1993, Jan-16, Volume: 341, Issue:8838

    Topics: Brain Diseases; Drug Administration Schedule; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Ultrasonography

1993
Early or selective surfactant (colfosceril palmitate, Exosurf) for intubated babies at 26 to 29 weeks gestation. A European double-blind trial with sequential analysis. European Exosurf Study Group.
    The Online journal of current clinical trials, 1992, Nov-10, Volume: Doc No 28

    Topics: Brain Diseases; Cysts; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Fatty Alcohols; Female; Gestational Age; Humans; Hydrocephalus; Infant, Newborn; Infant, Premature; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Treatment Outcome; Ultrasonography

1992